<DOC>
	<DOCNO>NCT02407496</DOCNO>
	<brief_summary>The purpose study develop new assessment tool Attention Deficit-Hyperactivity Disorder ( ADHD ) test validity ( i.e . ability discriminate individual ADHD healthy control ) .</brief_summary>
	<brief_title>Neurophysiological Attention Test ( NAT ) Objective Assessment Attention Deficit Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description>The purpose study develop novel approach software analyze electroencephalography ( EEG ) data identify biomarkers ADHD . Then test ability assessment tool differentiate adult ADHD healthy control compare classification accuracy metric new tool classification accuracy exist behavioral test ADHD .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>Specific inclusion criterion ADHD : 1. meet establish DSM5 criterion ADHD predominately inattentive combine subtype clinically significant level impairment , diagnose structured clinical interview , Mini International Neuropsychiatric Interview , corroborate information 2 . Clinical Global Impression—Severity ( CGIS ) score ≥ 4 ADHD 3. lifetime history DSM5 bipolar disorder , psychotic disorder , pervasive developmental disorder , obsessivecompulsive disorder , substance abuse , substance dependence ( except nicotine ) assess wit MINI 4. able opinion investigator complete require study procedure . Exclusion criterion group : 1 . History diagnosis childhood disorder ADHD ( e.g . autism , dyslexia ) 2. history general medical condition likely require chronic use medication identify CNS effect suspect alter cognitive performance 3. history seizure disorder , brain tumor , major neurological disorder head injury result loss consciousness 4. serious oxygen deprivation 5. current psychopathology require ongoing treatment antipsychotic medication , mood stabilizer , benzodiazepine , anticonvulsant 6. current untreated psychopathology rat primary term severity ( great ADHD severity ) 7. current treatment guanfacine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>